Reuters: U.S. FDA staff questions J&J antibiotic studies

[NaDiNe]

U.S. FDA staff questions J&J antibiotic studies
      

WASHINGTON (Reuters) - U.S. drug reviewers have "several major concerns" about the effectiveness data supplied by Johnson & Johnson in a bid to expand the use of its antibiotic Doribax (doripenem for injection), according to documents released on Monday.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login